73 related articles for article (PubMed ID: 21166945)
1. Identification of MAPK10 as a novel epigenetic marker for chromophobe kidney cancer.
Yoo KH; Park YK; Kim HS; Jung WW; Chang SG
Pathol Int; 2011 Jan; 61(1):52-4. PubMed ID: 21166945
[No Abstract] [Full Text] [Related]
2. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes.
Tsai YC; Huang CY; Hsueh YM; Fan YC; Fong YC; Huang SP; Geng JH; Chen LC; Lu TL; Bao BY
Life Sci; 2021 Jun; 275():119396. PubMed ID: 33774030
[TBL] [Abstract][Full Text] [Related]
4. Profilin 1 overexpression in renal cell carcinoma.
Minamida S; Iwamura M; Kodera Y; Kawashima Y; Ikeda M; Okusa H; Fujita T; Maeda T; Baba S
Int J Urol; 2011 Jan; 18(1):63-71. PubMed ID: 21091798
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
Pan CC; Chen PC; Chiang H
Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
[TBL] [Abstract][Full Text] [Related]
6. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.
Yusenko MV; Kovacs G
Histopathology; 2009 Dec; 55(6):687-95. PubMed ID: 20002769
[TBL] [Abstract][Full Text] [Related]
7. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
[TBL] [Abstract][Full Text] [Related]
8. Amplification of epidermal growth factor receptor gene in renal cell carcinoma.
El-Hariry I; Powles T; Lau MR; Sternberg CN; Ravaud A; von der Maase H; Zantl N; Harper P; Rolland F; Audhuy B; Barthel F; Machiels JP; Patel P; Kreuser ED; Hawkins RE
Eur J Cancer; 2010 Mar; 46(5):859-62. PubMed ID: 20167476
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
[TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage.
Zhang Q; Ying J; Li J; Fan Y; Poon FF; Ng KM; Tao Q; Jin J
J Urol; 2010 Aug; 184(2):731-7. PubMed ID: 20639048
[TBL] [Abstract][Full Text] [Related]
11. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
[TBL] [Abstract][Full Text] [Related]
12. RAR-beta(1) overexpression in chromophobe renal cell carcinoma: a novel target for therapeutic intervention?
Goelden U; Ukena SN; Pfoertner S; Hofmann R; Buer J; Schrader AJ
Exp Oncol; 2005 Sep; 27(3):220-4. PubMed ID: 16244585
[TBL] [Abstract][Full Text] [Related]
13. [Cytogenetic analysis of 19 renal cell tumors].
Cerasoli S; Spada F; Buda R; Turci A; Giangaspero F
Pathologica; 2001 Apr; 93(2):118-23. PubMed ID: 11428288
[TBL] [Abstract][Full Text] [Related]
14. Genetic markers in renal cell carcinomas.
McCue PA; Gorstein F
Hum Pathol; 2001 Oct; 32(10):1027-8. PubMed ID: 11679934
[No Abstract] [Full Text] [Related]
15. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization.
Speicher MR; Schoell B; du Manoir S; Schröck E; Ried T; Cremer T; Störkel S; Kovacs A; Kovacs G
Am J Pathol; 1994 Aug; 145(2):356-64. PubMed ID: 7519827
[TBL] [Abstract][Full Text] [Related]
16. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
[TBL] [Abstract][Full Text] [Related]
18. Expression of beta-catenin in renal cell carcinoma.
Zang T; Zhuang L; Zhang Z; Xin D; Guo Y
Chin Med J (Engl); 2001 Feb; 114(2):152-4. PubMed ID: 11780196
[TBL] [Abstract][Full Text] [Related]
19. Expression and mutational analyses of KIT and PDGFR-alpha in sarcomatoid renal cell carcinoma.
Petit A; Castillo M; Gaspa A; Colomer D; Garcia de Albéniz X; Moreno C; Camós M; Mellado B; Mallofré C
Histopathology; 2009 Aug; 55(2):230-2. PubMed ID: 19694830
[No Abstract] [Full Text] [Related]
20. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
